Alexandria’s Marcus Talks Up Cambridge
ByCheck out our outstanding speaker lineup plus network with your peers at RealShare BOSTON on July 22! Reserve your spot today.
Joel S. Marcus, chairman, CEO and founder of Alexandria Real Estate Equities, Inc.
CAMBRIDGE, MA—Joel S. Marcus, chairman, CEO and founder of Alexandria Real Estate Equities, Inc. tells Globest.com that his Pasadena, CA-based firm has never seen demand as strong for life science/biotech space here in the company’s 20-year history.
Alexandria owns 5.2 million square feet of life science/biotech space in the Cambridge area, which includes approximately 1 million square feet of space that will be under construction later this year. The REIT is currently building 50-60 Binney St., a two-building complex that will feature 530,000 square feet of rentable office/laboratory space. Genzyme, a subsidiary of pharmaceutical firm Sanofi, has leased 251,234 square feet there and will relocate from 500 Kendall Square in Cambridge when the 50 Binney St. building is completed in 2018…